Relmada Therapeutics Inc

NASDAQ RLMD

Data sourced from

and

Daily

Download Data

Relmada Therapeutics Inc Share Price on June 03, 2024: USD 3.08

Relmada Therapeutics Inc Share Price is USD 3.08 on June 03, 2024, a 8.07% change year over year. Share price refers to the current trading price of a single share of a company's stock. It represents the monetary value that investors are willing to pay for ownership in the company. Share prices are determined by the supply and demand dynamics in the stock market and can fluctuate throughout the trading day. Changes in share prices are influenced by various factors, including company performance, industry trends, market conditions, investor sentiment, and economic indicators. Share price is a key indicator used by investors to assess the performance and valuation of a company's stock.

Relmada Therapeutics Inc 52-week high Share Price is USD 6.80 on March 01, 2024, which is 120.78% above the current Share Price.
Relmada Therapeutics Inc 52-week low Share Price is USD 2.42 on June 27, 2023, which is -21.43% below the current Share Price.
Relmada Therapeutics Inc average Share Price for the last 52 weeks is USD 3.55.

NASDAQ: RLMD

Relmada Therapeutics Inc

CEO	Dr. Sergio Traversa M.B.A., MBA, Pharm.D., PharmD
IPO Date	Oct. 9, 2014
Location	United States
Headquarters	2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134
Employees	20
Sector	Healthcare
Industry	Biotechnology

Description

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.

Key trends